LINDSAY HICKS: Open Payments
NPI 1134626625 · SPRING CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 18 payments from 9 companies in 2025. Trend: 2023 $344 · 2024 $307 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| ABBVIE INC. | 4 | $78 |
| Lilly USA, LLC | 3 | $59 |
| Novo Nordisk Inc | 2 | $51 |
| Lundbeck LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, Ozempic, JARDIANCE, REXULTI, GVOKE HYPOPEN, GEMTESA, YUPELRI.
Industry payments across TN — which companies pay providers there.
